MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers - Lu, Thomas X.; Sherrill, Joseph D.; Wen, Ting; Plassard, Andrew J.; Besse, John A.; Abonia, Juan Pablo; Franciosi, James P.; Putnam, Philip E.; Eby, Michael; Martin, Lisa J.; Aronow, Bruce J.; Rothenberg, Marc E. (Journal of allergy and clinical immunology, 2012)
Keywords: adaptive immunity; Allergy and Immunology; Bioinformatics; Biological and medical sciences; biomarkers; Biopsy; Cell Count; Cluster Analysis; Disease; DNA methylation; Eosinophilia; Eosinophilic esophagitis; Eosinophilic Esophagitis - genetics; Eosinophilic Esophagitis - immunology; Eosinophils - immunology; Eosinophils - metabolism; esophageal diseases; Esophagitis; Esophagus; Esophagus - pathology; Fundamental and applied biological sciences. Psychology; Fundamental immunology; Gastroenterology. Liver. Pancreas. Abdomen; Gene expression; Gene Expression Profiling; gene expression regulation; Gene Expression Regulation - drug effects; Gene Regulatory Networks; Genetic Markers; glucocorticoid; Glucocorticoids; Glucocorticoids - pharmacology; Humans; Immunity; Immunopathology; Leukocytes (eosinophilic); Medical sciences; messenger RNA; microRNA; MicroRNAs; MicroRNAs - blood; MicroRNAs - genetics; miRNA; Other diseases. Semiology; patients; Polarization; Remission; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis; Studies; transcriptome; Translation; microRNA; miRNA; glucocorticoid; EoE; Eosinophilic esophagitis; biomarkers; Human; Immunopathology; RNA interference; Esophageal disease; Micro RNA; Biological marker; Esophagitis; Glucocorticoid; Eosinophil; Gene silencing; Immunology; Digestive diseases; Reversibility